Advanced Micro Devices reported second-quarter earnings on Tuesday that beat expectations, but the stock slumped in extended trading. Here's how the chipmaker did versus LSEG consensus estimates for the quarter ended June 27: - EPS: $1.66, adjusted, versus $1.62 expected -
US stocks finished sharply higher, with all of the major indices posting gains of at least 1.7% as risk appetite remained firmly in control. The rally was led by technology shares, pushing the Nasdaq indices to the top of the leaderboard, while the S&P 500 and Dow Industri
The water utility reported a $0.01 EPS miss and $20.4M revenue shortfall for Q2, despite year-over-year growth. Essential Utilities posted Q2 non-GAAP earnings per share of $0.38, missing estimates by $0.01. Revenue reached $530.9M, up 3.1% year-over-year but $20.4M below
Primoris Services reports Q2 non-GAAP EPS of -$0.27, exceeding expectations despite a $50M revenue miss. Primoris Services posted a Q2 non-GAAP EPS of -$0.27, beating estimates by $0.09. Revenue reached $1.69 billion, down 10.6% year-over-year and missing forecasts by $50
GXO Logistics reports Q2 GAAP EPS of $0.22 and revenue of $3.44B, both missing analyst estimates. GXO Logistics posted Q2 GAAP earnings per share of $0.22, missing expectations by $0.12. Revenue reached $3.44 billion, up 3.3% year over year but $20 million below forecasts.
Opendoor stock falls 9.47% after Q2 revenue misses estimates Opendoor Technologies' second-quarter revenue fell short of analyst expectations. The company's Q2 revenue miss led to a decline in its stock price. Shares were 9.47% lower at $3.73 during post-ma
BlackLine press release (BL): Q2 Non-GAAP EPS of $0.61 beats by $0.04. - Revenue of $187.8M (+9.2% Y/Y) beats by $0.77M. - Billings of $193.0 million, an increase of 5.9% compared to the second quarter of 2025. - Remaining performance obligation of $1.1 billion, an
Arista Networks reported Q2 adjusted EPS of $1.02, surpassing the $0.89 estimate and driving a post-market surge. Arista Networks (ANET) shares surged over 10% after reporting second-quarter 2026 adjusted earnings per share of $1.02, exceeding the $0.89 consensus estimate.
Pfizer projects 2026 revenue between $60.5 billion and $62.5 billion while aiming for $9.7 billion in net cost reductions by 2029. Pfizer announced a 2026 revenue guidance range of $60.5 billion to $62.5 billion during its Q2 2026 earnings call, citing strong execution and
Alphatec reaffirms full-year revenue outlook and raises adjusted EBITDA guidance after stronger-than-expected Q2 results. Alphatec reported Q2 revenue of $214M, exceeding estimates by $2.73M and marking a 15.3% year-over-year increase. Non-GAAP EPS matched expectations at
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.